These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9679957)
1. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Burgering BM; Coffer PJ Nature; 1995 Aug; 376(6541):599-602. PubMed ID: 7637810 [TBL] [Abstract][Full Text] [Related]
3. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518 [TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT; Leder P Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037 [TBL] [Abstract][Full Text] [Related]
8. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
9. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells. Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774 [TBL] [Abstract][Full Text] [Related]
10. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Mitsuuchi Y; Johnson SW; Sonoda G; Tanno S; Golemis EA; Testa JR Oncogene; 1999 Sep; 18(35):4891-8. PubMed ID: 10490823 [TBL] [Abstract][Full Text] [Related]
11. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines. Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774 [TBL] [Abstract][Full Text] [Related]
12. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153 [TBL] [Abstract][Full Text] [Related]
14. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921 [TBL] [Abstract][Full Text] [Related]
15. Translocation and activation of AKT2 in response to stimulation by insulin. Mitsuuchi Y; Johnson SW; Moonblatt S; Testa JR J Cell Biochem; 1998 Sep; 70(4):433-41. PubMed ID: 9712142 [TBL] [Abstract][Full Text] [Related]
16. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells. Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Arboleda MJ; Lyons JF; Kabbinavar FF; Bray MR; Snow BE; Ayala R; Danino M; Karlan BY; Slamon DJ Cancer Res; 2003 Jan; 63(1):196-206. PubMed ID: 12517798 [TBL] [Abstract][Full Text] [Related]
18. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes. Genot E; Reif K; Beach S; Kramer I; Cantrell D Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702 [TBL] [Abstract][Full Text] [Related]
19. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948 [TBL] [Abstract][Full Text] [Related]
20. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]